Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd (603707.SS) SHH
8.15
-0.13(-1.57%)
Currency In CNY
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 14.59B |
| Enterprise Value | 15.55B |
| P/E Ratio | 22.46 |
| PEG Ratio | -1.41 |
| Price/Sales Ratio | 3.26 |
| Price/Book Ratio | 1.88 |
| Enterprise/Revenue | 3.37 |
| Enterprise/EBITDA | 15.97 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.15 |
| Operating Margin | 0.18 |
Management Effectiveness
| Return On Assets | 0.05 |
| Return On Equity | 0.09 |
Income Statement
| Revenue | 3.97B |
| Revenue/Share | 2.5 |
| Gross Profit | 1.46B |
| EBITDA | 971.32M |
| Net Income | 581.54M |
| Diluted EPS | 0.36 |
Balance Sheet
| Total Cash | 3.39B |
| Total Cash/Share | 2.1 |
| Total Debt | 2.68B |
| Total Debt/Equity | 0.38 |
| Current Ratio | 2.27 |
| Book Value Per Share | 4.33 |
Price History
| 52-Week Change | -27.68 |
| 52-Week High | 12.27 |
| 52-Week Low | 7.89 |
| Moving Average 50 Days | 9.19 |
| Moving Average 200 Days | 9.81 |
Statistics
| Average Volume | 11.01M |
| Shares Outstanding | 1.62B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.1 |
| Trailing Annual Dividend Yield | 1.23 |
| Payout Ratio | 0.31 |
| Last Split Factor | 13:10 |
| Last Split Date | July 11, 2022 |
